These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
3. The anti-tumor effect of allogeneic bone marrow/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement? Har-Noy M; Slavin S Med Hypotheses; 2008; 70(6):1186-92. PubMed ID: 18054441 [TBL] [Abstract][Full Text] [Related]
5. Cytolytic pathways in haematopoietic stem-cell transplantation. van den Brink MR; Burakoff SJ Nat Rev Immunol; 2002 Apr; 2(4):273-81. PubMed ID: 12001998 [TBL] [Abstract][Full Text] [Related]
6. Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation. D'Aveni M; Notarantonio AB; Bertrand A; Boulangé L; Pochon C; Rubio MT Front Immunol; 2020; 11():989. PubMed ID: 32528476 [TBL] [Abstract][Full Text] [Related]
7. Nonmyeloablative transplantation for solid tumors: a new frontier for allogeneic immunotherapy. Espinoza-Delgado I; Childs RW Expert Rev Anticancer Ther; 2004 Oct; 4(5):865-75. PubMed ID: 15485320 [TBL] [Abstract][Full Text] [Related]
8. Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets. Stelljes M; Strothotte R; Pauels HG; Poremba C; Milse M; Specht C; Albring J; Bisping G; Scheffold C; Kammertoens T; Oelmann E; Silling G; Berdel WE; Kienast J Blood; 2004 Aug; 104(4):1210-6. PubMed ID: 15090450 [TBL] [Abstract][Full Text] [Related]
9. Differential requirement for a cellular type-1 immune response in tumor-associated versus alloantigen-targeted GvT effects. Stelljes M; Specht C; Albring J; Volkmann S; Schlösser V; Pauels HG; Poremba C; Bisping G; Opitz C; Scheffold C; Silling G; Kiehl M; Berdel WE; Kienast J Transplantation; 2007 Feb; 83(3):314-22. PubMed ID: 17297406 [TBL] [Abstract][Full Text] [Related]
10. Recombinant IL-7/HGFβ hybrid cytokine separates acute graft-versus-host-disease from graft-versus-tumour activity by altering donor T cell trafficking. Hu R; Liu Y; Song Y; Su M; Lu X; Rood D; Lai L Br J Haematol; 2016 Nov; 175(3):505-516. PubMed ID: 27447780 [TBL] [Abstract][Full Text] [Related]
11. [Hematopoietic stem cell transplantation: is it an immunologic therapy?]. Olaya Vargas A; Pérez Gonzáles O Rev Alerg Mex; 2003; 50(5):192-7. PubMed ID: 14631591 [TBL] [Abstract][Full Text] [Related]
12. Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation. Rezvani AR; Storb RF J Autoimmun; 2008 May; 30(3):172-9. PubMed ID: 18242060 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation. Du W; Cao X Front Immunol; 2018; 9():2979. PubMed ID: 30631325 [TBL] [Abstract][Full Text] [Related]
16. A TLR5 agonist enhances CD8(+) T cell-mediated graft-versus-tumor effect without exacerbating graft-versus-host disease. Ding X; Bian G; Leigh ND; Qiu J; McCarthy PL; Liu H; Aygun-Sunar S; Burdelya LG; Gudkov AV; Cao X J Immunol; 2012 Nov; 189(10):4719-27. PubMed ID: 23045613 [TBL] [Abstract][Full Text] [Related]
17. Will post-transplantation cell therapies for pediatric patients become standard of care? Lankester AC; Locatelli F; Bader P; Rettinger E; Egeler M; Katewa S; Pulsipher MA; Nierkens S; Schultz K; Handgretinger R; Grupp SA; Boelens JJ; Bollard CM; Biol Blood Marrow Transplant; 2015 Mar; 21(3):402-11. PubMed ID: 25064748 [TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy. Talmadge JE Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168 [TBL] [Abstract][Full Text] [Related]
19. [Allogeneic haematopoietic stem cell transplantation - an overview]. Holtick U; Chemnitz JM; Hallek M; Scheid C Klin Monbl Augenheilkd; 2015 May; 232(5):641-6. PubMed ID: 25989032 [TBL] [Abstract][Full Text] [Related]
20. Immunotherapeutic approaches to improve graft-versus-tumor effect and reduce graft-versus-host disease. Tsirigotis P; Or R; Resnick IB; Shapira MY Immunotherapy; 2012 Apr; 4(4):407-24. PubMed ID: 22512635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]